Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jason Grebely

Showing results (131-140 of 368) with videos related to

Pageof 37
Sort By:
The International Journal on Drug Policy|May 26, 2024
Patterns of drug use among people who inject drugs: A global systematic review and meta-analysisPaige Webb, Jeremy Ireland, Samantha Colledge-Frisby, et al.
The Journal of Molecular Diagnostics : JMD|July 8, 2015
Interferon λ 3 and 4 Genotyping Using High-Resolution Melt Curve Analysis Suitable for Multiple Clinical Sample TypesFrançois M J Lamoury, Sofia Bartlett, Brendan Jacka, et al.
Journal of Viral Hepatitis|May 11, 2019
Perceived barriers related to testing, management and treatment of HCV infection among physicians prescribing opioid agonist therapy: The C-SCOPE StudyAlain H Litwin, Martine Drolet, Chizoba Nwankwo, et al.
The Lancet. Infectious Diseases|May 1, 2012
Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccineJason Grebely, Maria Prins, Margaret Hellard, et al.
The International Journal on Drug Policy|April 1, 2025
Trends in cause-specific mortality among people with hepatitis C virus in New South Wales, AustraliaShane Tillakeratne, Heather Valerio, Maryam Alavi, et al.
The International Journal on Drug Policy|April 17, 2025
"It's not just running the test": Operator experiences of implementing a decentralised hepatitis C point-of-care testing program in AustraliaGrace K Burton-McKeich, Lise Lafferty, Carla Treloar, et al.
The International Journal on Drug Policy|December 22, 2019
Frequency of injecting among people who inject drugs: A systematic review and meta-analysisSamantha Colledge, Janni Leung, Sarah Larney, et al.
The Open Virology Journal|May 15, 2009
Clinical implications of mutations at reverse transcriptase codon 135 on response to NNRTI-based therapyHarout K Tossonian, Jesse D Raffa, Jason Grebely, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2013
Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysisEsther J Aspinall, Stephen Corson, Joseph S Doyle, et al.
The Lancet. Global Health|December 12, 2025
Addressing policy barriers to scaling up needle and syringe programmes: a global call to actionGuillaume Fontaine, Emma Day, Niklas Luhmann, et al.
Pageof 37

Showing results (131-140 of 368) with videos related to

Sort By:
Pageof 37
The International Journal on Drug Policy|May 26, 2024
Patterns of drug use among people who inject drugs: A global systematic review and meta-analysisPaige Webb, Jeremy Ireland, Samantha Colledge-Frisby, et al.
The Journal of Molecular Diagnostics : JMD|July 8, 2015
Interferon λ 3 and 4 Genotyping Using High-Resolution Melt Curve Analysis Suitable for Multiple Clinical Sample TypesFrançois M J Lamoury, Sofia Bartlett, Brendan Jacka, et al.
Journal of Viral Hepatitis|May 11, 2019
Perceived barriers related to testing, management and treatment of HCV infection among physicians prescribing opioid agonist therapy: The C-SCOPE StudyAlain H Litwin, Martine Drolet, Chizoba Nwankwo, et al.
The Lancet. Infectious Diseases|May 1, 2012
Hepatitis C virus clearance, reinfection, and persistence, with insights from studies of injecting drug users: towards a vaccineJason Grebely, Maria Prins, Margaret Hellard, et al.
The International Journal on Drug Policy|April 1, 2025
Trends in cause-specific mortality among people with hepatitis C virus in New South Wales, AustraliaShane Tillakeratne, Heather Valerio, Maryam Alavi, et al.
The International Journal on Drug Policy|April 17, 2025
"It's not just running the test": Operator experiences of implementing a decentralised hepatitis C point-of-care testing program in AustraliaGrace K Burton-McKeich, Lise Lafferty, Carla Treloar, et al.
The International Journal on Drug Policy|December 22, 2019
Frequency of injecting among people who inject drugs: A systematic review and meta-analysisSamantha Colledge, Janni Leung, Sarah Larney, et al.
The Open Virology Journal|May 15, 2009
Clinical implications of mutations at reverse transcriptase codon 135 on response to NNRTI-based therapyHarout K Tossonian, Jesse D Raffa, Jason Grebely, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2013
Treatment of hepatitis C virus infection among people who are actively injecting drugs: a systematic review and meta-analysisEsther J Aspinall, Stephen Corson, Joseph S Doyle, et al.
The Lancet. Global Health|December 12, 2025
Addressing policy barriers to scaling up needle and syringe programmes: a global call to actionGuillaume Fontaine, Emma Day, Niklas Luhmann, et al.
Pageof 37